Healthcare -
Biotechnology - NASDAQ - US
$ 0.3224
-2.75 %
$ 3.63 M
Market Cap
-0.01
P/E
CYCC - GROSS PROFIT
Gross Profit CYCC - Cyclacel Pharmaceuticals, Inc.
420 K
LAST VALUE
243.04%
2 YEAR CAGR
16.00%
5 YEAR CAGR
7.40%
10 YEAR CAGR